Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 158
Selected: 0
NCT IDTitle
NCT03967327A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain
NCT01376401Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma
NCT01957046A Single-arm, Study to Assess the Effect and Tolerability of Standardised Laxative Therapy (SLT) for the Reversal of Opioid-induced Constipation (OIC).
NCT02094560CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors
NCT01710904A Non-interventional, Observational Study for Targinact® Treatment in Patients With Chronic Severe Pain
NCT01083485OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee Arthroplasty
NCT02256202Quality Assurance of Electronic Data Capturing (EDC) in Pain Treatment
NCT01811186An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY)
NCT01675622Immediate-Release Oxycodone Capsules Study in Cancer Pain
NCT02326454A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
NCT03155516Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain Patients
NCT03585374Trauma Acute Pain Treatment With Methoxyflurane Vaporized (PENTHROX®): Efficacy and Safety Study (MEDITA)
NCT02452112Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain
NCT01983137A Non-interventional, Observational Study for Targinact® Treatment in Patients With Severe Pain.
NCT03348917The Effect of Skin Cleansers on the Skin Surface Microbiome
NCT03150602A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy
NCT00823355Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies
NCT00412100Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation
NCT02740621The Impact of Opioids in Coronary Heart Disease
NCT03062644Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2.
NCT01457144Study of Mantle Cell Lymphoma Treatment by RiBVD
NCT02160067A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches
NCT03176199A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain
NCT03398278OTR Tablet 40 mg Fasted-state Bioequivalence Study
NCT01643772OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study
NCT02753712A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma
NCT00963534Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.
NCT03403504OTR Tablet 10 mg Fasted-state Bioequivalence Study
NCT00426647Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine
NCT00646165Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia
NCT04053608Human Physiology and Self-Reported Pain Score
NCT01225861Prospective Study on the Use of Transdermal Analgesic Buprenorphine Patches for Chronic Pain in the UK
NCT00995800Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma
NCT05835479Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults
NCT01439100A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain
NCT00734318Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma
NCT02693769A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils
NCT04279938A Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCL
NCT01002703Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma
NCT02268422Bioequivalence and Adhesion Comparison of Buprenorphine Patches
NCT01112644Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms
NCT02321397To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT02491970Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/Salmeterol
NCT01776411Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients
NCT01109511A Comparison of Oxycodone/Naloxone and Oxycodone After Laparoscopic Hysterectomy
NCT01167699Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT00801216High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement
NCT04368559Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
NCT00563056An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma
NCT02237261Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma